CD163 and central nervous system cancer: The results revealed that compared with low-grade gliomas, the intensity of CD163 protein in high-grade gliomas was also enhanced (P < 0.05), and there was a good match between ISG20 and CD163 expression in the serial sections (Fig. 9A and B).